4//SEC Filing
Graham Camilla 4
Accession 0000921895-20-002557
CIK 0001599298other
Filed
Oct 6, 8:00 PM ET
Accepted
Oct 7, 7:47 PM ET
Size
5.7 KB
Accession
0000921895-20-002557
Insider Transaction Report
Form 4
Graham Camilla
Chief Clinical Affairs Officer
Transactions
- Award
Stock Option (right to buy)
2020-10-04$3.34/sh+400,000$1,336,000→ 400,000 totalExercise: $3.34Exp: 2030-10-04→ Common Stock (400,000 underlying)
Footnotes (1)
- [F1]The option was granted on October 4, 2020 pursuant to the Company's 2020 Stock Incentive Plan. The shares underlying the option are scheduled to vest in four equal annual installments, with the first such installment occurring on October 4, 2021, subject to the satisfaction of certain performance targets.
Documents
Issuer
Summit Therapeutics Inc.
CIK 0001599298
Entity typeother
Related Parties
1- filerCIK 0001827543
Filing Metadata
- Form type
- 4
- Filed
- Oct 6, 8:00 PM ET
- Accepted
- Oct 7, 7:47 PM ET
- Size
- 5.7 KB